Mayo Clinic adds GLP-1s to its weight loss program: It’s yet another option for consumers to get prescriptions for obesity medications. Will Mayo’s esteemed clinical reputation set it apart from competitors?
Digital health startups to watch: We spotlight medication management platform DecisionRx and suicide prevention provider Vita Health on the back of fresh funding.
Younger generations are making D2C health purchases: We explore which factors are driving the trend and examine the opportunity for healthcare brands and marketers.
Telehealth isn’t getting better: Patients who had an initial telehealth visit were more likely to need a follow-up appointment than patients who had an office visit. Geography plays a part that marketers should know about.
ACA enrollment sets a new record: 20.4 million people signed up for health insurance coverage via the Affordable Care Act marketplaces before the start of 2024. But it’s not all good news.
On today's podcast episode, we discuss how this year will look as Google's cookies fade away, the biggest threat to Google's search dominance, how many consumers are moving to ad-supported streaming, whether Apple can move the VR needle, Peloton's content hub on TikTok, the first person to ever complete Tetris, and more. Tune in to the discussion with our analysts Ross Benes, Evelyn Mitchell-Wolf, and Max Willens.
Digital health startups to watch: We spotlight healthcare AI assistant Nabla and obesity care provider Knownwell on the back of fresh funding.
Hims & Hers secures another healthcare provider partner: The tie-ups drive referrals to larger health systems while helping Hims & Hers retain members.
Calling some Elevance Medicaid members: Elevance Health collaborated with Samsung and telecom giants to give eligible members customized smartphones. It’s a retention ploy in a market with a lot of churn.
Amazon, Omada partner on digital health benefits program: We unpack the tech giant’s latest healthcare endeavor and explore how Amazon can help digital health companies enroll more members.
Digital health venture funding fell back to 2019 levels: And things aren’t looking up for companies that are running out of cash. Expect a lot more M&A or shutdowns in 2024.
Mayo Clinic forges more deals to improve AI models: It signed deals with Cerebras Systems and TruLite Health to build foundational AI models. The results could build more trust in the tech among healthcare organizations.
Eli Lilly debuts D2C website for Rx access: We examine the drugmaker’s ambitions and explore how it will impact patients and other pharma players.
Employers need tools to assess employees’ health risks: HeartRisk is a new tool that employers can use to gauge their workforce’s risk of heart disease. It’s just one of many preventive care solutions employers are seeking in 2024.
More healthcare providers and insurers are revealing prices: Almost 91% of hospitals posted some prices for services and procedures in 2023. The federal gov’t is continuing to push for even more transparency in 2024.
Pharma still loves traditional TV ads, even as audiences tune out: Drug advertisers spent $4.37 billion on TV ads in 2023 and will likely spend more in 2024. But even older adults are turning to digital channels.
Digital health startups to watch: We spotlight insurtech Devoted Health and metabolic disease platform Twin Health on the back of fresh funding.
Swoop’s predictive AI enables pharma marketers to target even undiagnosed patients: It’s the latest example of how AI models are helping pharma brands reach more patients and providers.
Peloton is the latest to try out TikTok’s brand hubs: The fitness company is the second major brand to try TikTok’s innovative ad format after Disney in October.
Weight loss drugs work, but adherence rates are a mixed bag: Marketers know the better a product works, the longer consumers will use it. But less than half of adults were still taking these meds after three months. We dig into more research findings.